BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 16859523)

  • 41. Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer.
    Parikh RR; Housman D; Yang Q; Toppmeyer D; Wilson LD; Haffty BG
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1056-63. PubMed ID: 18676094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of radiotherapy on the incidence and time of occurrence of local recurrence in early-stage breast cancer after breast conserving therapy.
    Fodor J; Major T; Polgár C; Tóth J; Németh G
    Neoplasma; 2000; 47(3):181-6. PubMed ID: 11043843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Consequences of axillary recurrence after conservative breast surgery.
    Fredriksson I; Liljegren G; Arnesson LG; Emdin SO; Palm-Sjövall M; Fornander T; Holmqvist M; Holmberg L; Frisell J
    Br J Surg; 2002 Jul; 89(7):902-8. PubMed ID: 12081741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer.
    Voogd AC; de Boer R; van der Sangen MJ; Roumen RM; Rutten HJ; Coebergh JW
    Eur J Surg Oncol; 2001 Apr; 27(3):250-5. PubMed ID: 11373100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Repeat Sentinel Lymph Node Biopsy for Ipsilateral Breast Tumor Recurrence: A Systematic Review of the Results and Impact on Prognosis.
    Poodt IGM; Vugts G; Schipper RJ; Nieuwenhuijzen GAP
    Ann Surg Oncol; 2018 May; 25(5):1329-1339. PubMed ID: 29468606
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Favorable outcome of secondary axillary dissection in breast cancer patients with axillary nodal relapse.
    Shen SC; Liao CH; Lo YF; Tsai HP; Kuo WL; Yu CC; Chao TC; Chen MF; Chang HK; Lin YC; Shen WC; Ueng SH; Lee LY; Hsueh S; Huang YT; Chen SC
    Ann Surg Oncol; 2012 Apr; 19(4):1122-8. PubMed ID: 21969085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer.
    Dalberg K; Mattsson A; Sandelin K; Rutqvist LE
    Breast Cancer Res Treat; 1998 May; 49(1):69-78. PubMed ID: 9694613
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting local recurrence following breast-conserving treatment: parenchymal signal enhancement ratio (SER) around the tumor on preoperative MRI.
    Kim MY; Cho N; Koo HR; Yun BL; Bae MS; Chie EK; Moon WK
    Acta Radiol; 2013 Sep; 54(7):731-8. PubMed ID: 23550189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
    Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
    JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Supraclavicular nodal failure in patients with one to three positive axillary lymph nodes treated with breast conserving surgery and breast irradiation, without supraclavicular node radiation.
    Reddy SG; Kiel KD
    Breast J; 2007; 13(1):12-8. PubMed ID: 17214788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy: risk factors of IBTR and validation of the MD Anderson Prognostic Index.
    Ishitobi M; Ohsumi S; Inaji H; Ohno S; Shigematsu H; Akiyama F; Iwase T; Akashi-Tanaka S; Sato N; Takahashi K; Oura S
    Cancer; 2012 Sep; 118(18):4385-93. PubMed ID: 22252882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy.
    Dinshaw KA; Budrukkar AN; Chinoy RF; Sarin R; Badwe R; Hawaldar R; Shrivastava SK
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1132-41. PubMed ID: 15978744
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy.
    Truong PT; Yong CM; Abnousi F; Lee J; Kader HA; Hayashi A; Olivotto IA
    J Am Coll Surg; 2005 Jun; 200(6):912-21. PubMed ID: 15922205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Breast-conserving treatment for early invasive lobular breast cancer: 15 years results].
    Fodor J; Sulyok Z; Polgár C; Major T; Tóth J; Németh G
    Magy Seb; 2001 Aug; 54(4):209-14. PubMed ID: 11550486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Uncontrolled local disease after salvage treatment for ipsilateral breast tumour recurrence.
    Dalberg K; Liedberg A; Johansson U; Rutqvist LE
    Eur J Surg Oncol; 2003 Mar; 29(2):143-54. PubMed ID: 12633557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Breast-conserving therapy after neoadjuvant chemotherapy: long-term results.
    Beriwal S; Schwartz GF; Komarnicky L; Garcia-Young JA
    Breast J; 2006; 12(2):159-64. PubMed ID: 16509842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J
    Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
    J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
    Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
    Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.